US Stock MarketDetailed Quotes

SAB Biotherapeutics (SABS)

Watchlist
  • 3.960
  • +0.340+9.39%
Close May 13 16:00 ET
  • 3.900
  • -0.060-1.52%
Post 18:54 ET
302.80MMarket Cap-6.83P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SAB Biotherapeutics (SABS) Revenue Breakdown Overview

By Business/Source

Currency:USD
2024/FY
Stock NameRevenueRatio
Development of a human anti-thymocyte globulin focused on preventing or delaying the progression of1.32M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States1.32M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -